Adelaide researchers have identified a promising new biomarker and treatment target for ovarian cancer that could markedly ...
Ovarian cancer (OC), one of the three most common gynecological malignancies, is characterized by low early detection rates and poor prognosis. Patients with OC face a high risk of developing ...
Cancer immunotherapy, which uses drugs that stimulate the body's immune cells to attack tumors, is a promising approach to ...
Adelaide researchers have identified a promising new biomarker and treatment target for ovarian cancer that could markedly ...
(A) Schematic design of an experiment for identifying metastasis-related genes using a CRISPR/Cas9 library in an orthotopic murine model of OC. (B) The bioluminescence signals and quantifications of ...
Image Caption: Proteomic alterations in post-NACT OCPM tissues. Genes & Diseases publishes rigorously peer-reviewed and high quality original articles and authoritative reviews that focus on the ...
Tumor Treating Fields With Gemcitabine and Nab-Paclitaxel for Locally Advanced Pancreatic Adenocarcinoma: Randomized, Open-Label, Pivotal Phase III PANOVA-3 Study This is a single-institution ...
New Data Highlight Continued Potential of Radspherin to Prevent Disease Progression OSLO, Norway, Oct. 8, 2025 /PRNewswire/ -- Oncoinvent ASA, a clinical-stage ...
Christiane Amanpour has been diagnosed with cancer again. The 67-year-old chief international anchor for CNN shared the news ...
Stage 2 ovarian cancer means the cancer is present in one or both ovaries and has spread to other pelvic tissues, such as the ...
The annual event will be held Saturday, Nov. 8 from 8 a.m. - 12 p.m. at Cranes Roost Park in Altamonte Springs.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback